Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trial.

Source:http://linkedlifedata.com/resource/pubmed/id/17693380

Download in:

View as

General Info

PMID
17693380